$HDRE - President's Letter to Shareholders From the desk

New Post Public Reply Private Reply Replies (0) Message Board
wholelotamoney
$HDRE - President's Letter to Shareholders

From the desk of the President of HD Retail Solutions, Inc. April 20, 2014

To the Shareholders of HD Retail Solutions, Inc., (HDRE):

I am writing to you today with good news. As you may know, I have spent a great deal of time and energy to the goal of sharing with my fellow shareholders the opportunity to participate in a separate venture known as Greenscape Laboratories, Inc.

As a result of new hurdles to the proposed transaction, I am rescinding the proposed dividend transaction and withdrawing the S-1. Rather than deny you the benefits of the Greenscape Laboratories, Inc. venture that many of you have been waiting for, I am resolving the issue a different way. The result is two-fold. First, it brings immediate benefit of the Greenscape venture to HDREs shareholders. Second, I will be more able to focus on developing the companys operations rather than devoting so much time and attention to non-productive and expensive regulatory filings.

The time you have been waiting for is NOW.

HD Retail Solutions, Inc. is formally acquiring the assets of Greenscape Laboratories with the exception of Greenscapes bank accounts. Because the company is not being transferred, but only the assets, shareholders of HDRE will not be exposed to any contingent liabilities of Greenscapes.

Ten million common shares will be issued by HD Retail Solutions, Inc. as the purchase price. These will be restricted for one year, so there will be no dilution to current shareholders from acquiring Greenscapes assets.

The company is applying for a change of name to Greenscape Laboratories, Inc. and will also pursue a change in the stock symbol.

The company will also be increasing the authorized number of shares. It anticipates using shares to acquire existing competitive facilities or other assets necessary to operate Greenscape?s facilities and retain personnel needed to conduct testing facilities.

There will be no immediate change to the management of HDRE, but we anticipate the addition of directors and/or consultants to assist with various technical, marketing and other issues.


Greenscapes plans going forward:

Greenscape intends to expand the company both organically and by acquisition using stock. Although our goal is to make all actions immediately accretive, management is more interested in the long-term growth than in immediate returns on investment.

Greenscape has already begun reaching out to potential competitors in the testing business to acquire portions of, or all of, existing facilities in Colorado, Oregon and Washington.

Greenscape intends to begin its own testing operations as soon as practical using its own equipment without damaging on-going discussions where existing facilities are located.

Although Greenscape?s initial expansion plans center on states allowing recreational marijuana use, it is evaluating expansion to those states where medical marijuana is allowed.

Clarifications:

Yes, we will be testing marijuana for the presence of toxins, the level of CBDs, CBNs and THC.

Yes, we will be presenting a new website (mjnalab.com) and we will use it as our primary social media contact point.

Yes, we will also employ a Facebook page, and ask that you like it. We intend on posting all news-worthy items on the page.

Yes, we will be making Press Releases to update shareholders and the markets of relevant actions taken by the company and items that may affect the companys operations in the marijuana industry.

Yes, we will respond to inquiries made via the webpage.



Sincerely,

James R. J. Scheltema, CPA, Esq.

Contact:

HD Retail Solutions, Inc.

info@hdretailsolutions.com

800-451-6133

Ultrack Systems, Inc. (MJLB) Stock Research Links

MJLB Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 188

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 384

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 260

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 267

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 392

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 382

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
Luvme Hair Offers Wig Variety for Winter Fashion

Updated Category News Views 371

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices

Updated Category News Views 472

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 344

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 433

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
/news?page=2">More News Articles